Drug Development Executive

Drug Development Executive

Clinical/Medical

The Buzz Around GLP-1 Microdosing

Hype vs. Science

Eswar Krishnan, MD's avatar
Eswar Krishnan, MD
May 29, 2025
∙ Paid

How Prevalent Is Microdosing?

While complex data is scarce, the practice is gaining traction, primarily fueled by online discussions and social media platforms. A recent survey even indicated that as many as 36% of GLP-1 users might be microdosing, often learning about the practice through channels like TikTok.

Is this a new phenomenon?

Not at all. Those o…

User's avatar

Continue reading this post for free, courtesy of Eswar Krishnan, MD.

Or purchase a paid subscription.
© 2026 Eswar Krishnan · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture